NASDAQ · ANIX
Anixa Biosciences, Inc.
Healthcare · Biotechnology
$2.99
Up+$0.17 (+5.69%)
Updated Nov 3, 2026, 3:31 PM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 99.47M
- P/E ratio
- -8.85
- Dividend yield
- 0.00%
- 52-week range
- $2.32 – $5.46
- Volume
- 128.34K
- Avg. volume
- 307.4K
Price performance · ANIX
ANIX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
ANIX closed at $2.99 after 21 trading sessions, up 1.36% for the selected period.
- Last close
- $2.99
- Period change
- +1.36%
- Period low
- $2.61
- Period high
- $3.37
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $3.14 | $3.1513 | $2.98 | $2.99 | 128.34K |
| Oct 30, 2026 | $3.28 | $3.35 | $3.10 | $3.12 | 140.66K |
| Oct 29, 2026 | $3.40 | $3.4394 | $3.28 | $3.30 | 136.58K |
| Oct 28, 2026 | $3.26 | $3.43 | $3.20 | $3.37 | 251.54K |
| Oct 27, 2026 | $2.95 | $3.34 | $2.945 | $3.28 | 497.9K |
| Oct 26, 2026 | $2.94 | $2.98 | $2.89 | $2.93 | 135.64K |
| Oct 23, 2026 | $2.80 | $3.14 | $2.74 | $2.99 | 326.69K |
| Oct 22, 2026 | $2.70 | $2.78 | $2.68 | $2.78 | 156.81K |
| Oct 21, 2026 | $2.68 | $2.746 | $2.655 | $2.71 | 115.73K |
| Oct 20, 2026 | $2.64 | $2.75 | $2.64 | $2.68 | 166.8K |
| Oct 19, 2026 | $2.67 | $2.69 | $2.60 | $2.61 | 91.27K |
| Oct 16, 2026 | $2.79 | $2.8199 | $2.645 | $2.67 | 123.53K |
| Oct 15, 2026 | $2.66 | $2.79 | $2.63 | $2.78 | 223.34K |
| Oct 14, 2026 | $2.75 | $2.818 | $2.63 | $2.655 | 228.44K |
| Oct 13, 2026 | $2.84 | $2.8401 | $2.66 | $2.67 | 175.82K |
| Oct 12, 2026 | $2.90 | $2.92 | $2.83 | $2.84 | 97.74K |
| Oct 9, 2026 | $2.93 | $2.96 | $2.86 | $2.90 | 217.88K |
| Oct 8, 2026 | $2.93 | $2.93 | $2.86 | $2.91 | 259.95K |
| Oct 7, 2026 | $3.01 | $3.0559 | $2.93 | $2.95 | 245.25K |
| Oct 6, 2026 | $2.95 | $3.11 | $2.87 | $3.02 | 344.96K |
| Oct 5, 2026 | $2.98 | $2.99 | $2.875 | $2.95 | 369.46K |
Latest ANIX news
The latest Smart Investors Daily articles mentioning ANIX.
Stock researchMarket Activity · Sentiment
Company
Market Activity
Research & News

